Cargando…
Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation
To reduce hepatitis B virus reinfection after liver transplantation (LT), patients often receive antihepatitis B immunoglobulin (HBIG) alone or combined with antiviral nucleoside/nucleotide analogs (NUCs); however, proximal renal tubular dysfunction (RTD) that was induced by NUCs in liver recipients...
Autores principales: | Lee, Jae Geun, Lee, Juhan, Lee, Jung Jun, Song, Seung Hwan, Ju, Man Ki, Choi, Gi Hong, Kim, Myoung Soo, Choi, Jin Sub, Kim, Soon Il, Joo, Dong Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635758/ https://www.ncbi.nlm.nih.gov/pubmed/26402818 http://dx.doi.org/10.1097/MD.0000000000001569 |
Ejemplares similares
-
Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation
por: Lee, Jae Geun, et al.
Publicado: (2016) -
Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005) -
Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015) -
Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
por: Woo, Hyun Young, et al.
Publicado: (2014) -
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
por: Kim, Jeong Han, et al.
Publicado: (2013)